Skip to main content

Formulary Frontlines

First Report Managed Care
An understanding of the factors that contribute to treatment burden of AMD may help clinicians develop strategies to lessen its impact and help patients to better manage the challenges of treatment.
First Report Managed Care
With the advent of calcitonin gene-related peptide (CGRP) inhibitors, which are either monoclonal antibodies or CGRP receptor agonists that block CGRP proteins in the head and neck, another treatment option has emerged for patients where other therapies have failed.
First Report Managed Care
In addition to physical and emotional impact of MS, the economic burden is considerable, ranking second among all chronic conditions in direct costs behind congestive heart failure.
First Report Managed Care
Although hemophilia is designated an orphan disease by the FDA because it affects fewer than 200,000 people in the United States, it imposes a significant financial and burden on patients, caregivers, and society.
First Report Managed Care
While great strides have been made in treating people with HIV over the past few decades, the US Preventive Task Force is strongly recommending PrEP for anyone at risk to help prevent the spread of the disease with which approximately 1.1 million people in the US are currently living.
First Report Managed Care
AML is the most common acute leukemia in adults with an estimated 21,450 new cases expected in 2019 in the United States and approximately 10,920 deaths. In this segment, we explore various treatments for AML.
First Report Managed Care
Russel Spjut, PharmD, discusses various treatment options for diabetes, as well as explores the most recent technologies aimed at improving management of the disease.
First Report Managed Care
Asthma is a condition of hypersensitivity to common exposures associated with chronic airway inflammation, bronchial hyperreactivity with increased mucus and airway edema, obstruction, and narrowing. Barbara Yawn, MD, MSc, FAFFP, outlines latest treatments and discusses costs.
First Report Managed Care
Rheumatoid arthritis (RA) continues to affect as many as 1.5 million adults in the United States.
First Report Managed Care
Neuroendocrine tumors (NETs) are thought to arise from cells throughout the diffuse endocrine system.
Back to Top